Carbamoylcholine-hydrochloride en es it fr

Carbamoylcholine-hydrochloride Brand names, Carbamoylcholine-hydrochloride Analogs

Carbamoylcholine-hydrochloride Brand Names Mixture

  • No information avaliable

Carbamoylcholine-hydrochloride Chemical_Formula


Carbamoylcholine-hydrochloride RX_link

Carbamoylcholine-hydrochloride fda sheet

Carbamoylcholine-hydrochloride FDA

Carbamoylcholine-hydrochloride msds (material safety sheet)

Carbamoylcholine-hydrochloride MSDS

Carbamoylcholine-hydrochloride Synthesis Reference

No information avaliable

Carbamoylcholine-hydrochloride Molecular Weight

147.196 g/mol

Carbamoylcholine-hydrochloride Melting Point

210 oC

Carbamoylcholine-hydrochloride H2O Solubility

1 g/ml

Carbamoylcholine-hydrochloride State


Carbamoylcholine-hydrochloride LogP


Carbamoylcholine-hydrochloride Dosage Forms

Liquid; Solution; Tablet

Carbamoylcholine-hydrochloride Indication

Primarily used in the treatment of glaucoma, but is also used during ophthalmic surgery.

Carbamoylcholine-hydrochloride Pharmacology

Carbachol is a potent cholinergic (parasympathomimetic) agent which produces constriction of the iris and ciliary body resulting in reduction in intraocular pressure. The exact mechanism by which carbachol lowers intraocular pressure is not precisely known. In the cat and rat, carbachol is well-known for its ability to induce rapid eye movement (REM) sleep when microinjected into the pontine reticular formation. Carbachol elicits this REM sleep-like state via activation of postsynaptic muscarinic cholinergic receptors (mAChRs).

Carbamoylcholine-hydrochloride Absorption

Not well absorbed in the gastro-intestinal tract, and does not cross the blood-brain barrier.

Carbamoylcholine-hydrochloride side effects and Toxicity

Oral, mouse: LD50 = 15 mg/kg; Oral, rat: LD50 = 40 mg/kg.

Carbamoylcholine-hydrochloride Patient Information

No information avaliable

Carbamoylcholine-hydrochloride Organisms Affected

Humans and other mammals